Case Study: Sestina Bio accelerates synthetic biology screening with Culture Biosciences

Sestina Bio generates 100x more data with Culture Biosciences

Sestina Bio, a company developing a data-driven synthetic biology platform, faced the challenge of screening new microbial strains. They were skeptical that a third-party provider could meet their rigorous standards for high-quality, reproducible data from bioreactor experiments and had originally planned to invest over $1 million to build an in-house lab.

Culture Biosciences addressed this by first proving its capabilities through a technical transfer and scale-down validation project, demonstrating it could meet Sestina's exacting data quality requirements. Sestina ultimately adopted Culture's Guaranteed Capacity subscription service. The solution provided Sestina with higher-quality data, significant cost savings by avoiding capital expenditure, and the flexibility to scale capacity as needed. This partnership allowed Sestina to accelerate its R&D and hire a Director of Fermentation to focus on analysis instead of lab management.

Sestina Bio